Offer - Urjas Oil for just ₹ 1 X
Levasol M 100/150 Tablet is a commercial drug that is prescribed in the form of Tablet. Other than this, Levasol M 100/150 Tablet has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Levasol M 100/150 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Levasol M 100/150 Tablet can also lead to other problems, which have been listed below. Normally, these side effects of Levasol M 100/150 Tablet are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Levasol M 100/150 Tablet is Moderate for pregnant women and Moderate for women who are breastfeeding. Further, the section on Levasol M 100/150 Tablet related warnings talks about Levasol M 100/150 Tablet's effects on the liver, heart and kidney.
Other conditions have been mentioned below in the Levasol M 100/150 Tablet contraindications section.
Additionally, Levasol M 100/150 Tablet may also adversely react with other medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Levasol M 100/150 Tablet is considered not safe while driving, and is not addictive.
Levasol M 100/150 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Levasol M 100/150 Tablet safe for pregnant women?
Levasol M can have harmful effects in pregnant women. If you experience any discomfort after using Levasol M, then discontinue the use and take your doctor's advice.
Is the use of Levasol M 100/150 Tablet safe during breastfeeding?
Levasol M can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Levasol M 100/150 Tablet on the Kidneys?
Information about safety of Levasol M for kidney is not available since scientific research on this topic is yet to be done.
What is the effect of Levasol M 100/150 Tablet on the Liver?
There is no research available on the side effects of Levasol M on the liver. Therefore, its impact is unknown.
What is the effect of Levasol M 100/150 Tablet on the Heart?
Levasol M is not harmful for the heart.
Levasol M 100/150 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Levasol M 100/150 Tablet unless your doctor advises you to do so -
Is this Levasol M 100/150 Tablet habit forming or addictive?
Levasol M 100/150 Tablet does not cause addiction.
Interaction between Food and Levasol M 100/150 Tablet
Taking Levasol M 100/150 Tablet with food does not cause any problems.
Interaction between Alcohol and Levasol M 100/150 Tablet
Consult your doctor before consuming alcohol while taking Levasol M 100/150 Tablet as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vermox™ Chewable (mebendazole chewable tablets)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 849-850
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 852
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ergamisol (levamisole hydrochloride)